SCHEMBL8345130

SCHEMBL8345130

CC(C)(C)OC(=O)Nc1cccc(N2C(=O)CCN2C(=O)OC(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
GPR119 Q8TDV5 2/20 0.41
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PARP14 Q460N5 1/20 0.39
NR1I3 Q14994 2/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
CYP17A1 P05093 1/20 0.39
NPY1R P25929 1/20 0.38
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8191150 0.86 DRD2 (0.43) CYP17A1DRD2LIPECA12CA1
SCHEMBL8224630 0.82 STS (0.43) GPR119RXFP1
SCHEMBL8198043 0.81 GPR119 (0.48) GPR119
SCHEMBL8191152 0.77 LIPE (0.39) GAANR1I3PRMT5WDR77DRD2
SCHEMBL27468254 0.74 GPR119 (0.43) GPR119BRD4CREBBPHCRTR1HCRTR2
SCHEMBL1968536 0.74 DDB1 (0.45) GAABRD4CREBBPHCRTR1HCRTR2
SCHEMBL8194646 0.73 GPR119 (0.46) GAAGPR119
SCHEMBL29029431 0.73 HDAC3 (0.56) BRD4CREBBPHCRTR1HCRTR2HDAC3
SCHEMBL1112019 0.73 MAPT (0.46) GAAGPR119BRD4HCRTR1HCRTR2
SCHEMBL8471288 0.71 GPR119 (0.57) GPR119HCRTR1PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962496-A CENTRAL NERVOUS SYSTEM DISORDERS GLAXO WELLCOME SPA (IT) 1999-10-05 US disclosed
US-5760059-A ANTAGONISTS OF EXCITATORY AMINO ACIDS, TREATMENT OF NEURODEGENERATIVE DISEASES GLAXO WELLCOME SPA (IT) 1998-06-02 US disclosed